Arcellx IncNASDAQ:ACLX
- LAST PRICE53.7500
- TODAY'S CHANGE (%)-0.6600 (-1.2130%)
- Bid / Lots52.7500/ 1
- Ask / Lots59.4600/ 1
- Open / Previous Close54.3700 / 54.4100
- Day Range
- 52 Week Range
- Volume647,990
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACLX |
|---|---|---|
| 09:32 ET | 3351 | 54.63 |
| 09:34 ET | 100 | 54.3 |
| 09:36 ET | 100 | 54.305 |
| 09:38 ET | 400 | 54.16 |
| 09:43 ET | 200 | 54.69 |
| 09:48 ET | 1859 | 53.95 |
| 09:50 ET | 300 | 54.05 |
| 09:52 ET | 200 | 53.96 |
| 09:54 ET | 2145 | 53.67 |
| 09:56 ET | 500 | 53.84 |
| 09:57 ET | 400 | 53.93 |
| 09:59 ET | 700 | 54.35 |
| 10:01 ET | 3081 | 54.315 |
| 10:03 ET | 2800 | 54.2 |
| 10:06 ET | 1700 | 53.945 |
| 10:08 ET | 4280 | 53.94 |
| 10:10 ET | 100 | 54.04 |
| 10:12 ET | 800 | 53.905 |
| 10:14 ET | 100 | 53.925 |
| 10:15 ET | 1265 | 53.9 |
| 10:17 ET | 1200 | 54.13 |
| 10:26 ET | 1098 | 53.97 |
| 10:28 ET | 600 | 54.01 |
| 10:30 ET | 700 | 53.89 |
| 10:32 ET | 900 | 53.725 |
| 10:33 ET | 700 | 53.71 |
| 10:35 ET | 1092 | 53.86 |
| 10:39 ET | 100 | 54 |
| 10:46 ET | 1304 | 54.005 |
| 10:50 ET | 200 | 54.045 |
| 10:51 ET | 800 | 53.895 |
| 10:53 ET | 500 | 53.975 |
| 10:57 ET | 100 | 53.96 |
| 11:00 ET | 100 | 53.915 |
| 11:02 ET | 300 | 53.89 |
| 11:04 ET | 100 | 53.88 |
| 11:06 ET | 7636 | 53.7 |
| 11:08 ET | 4000 | 53.83 |
| 11:09 ET | 2498 | 54.06 |
| 11:11 ET | 800 | 54.1 |
| 11:13 ET | 1100 | 53.995 |
| 11:15 ET | 200 | 53.9975 |
| 11:20 ET | 1500 | 53.975 |
| 11:22 ET | 100 | 53.995 |
| 11:24 ET | 1200 | 53.915 |
| 11:26 ET | 760 | 53.85 |
| 11:27 ET | 5307 | 53.735 |
| 11:29 ET | 421 | 53.96 |
| 11:31 ET | 600 | 53.925 |
| 11:33 ET | 500 | 53.95 |
| 11:36 ET | 500 | 53.905 |
| 11:38 ET | 3256 | 54.1 |
| 11:40 ET | 300 | 53.965 |
| 11:42 ET | 800 | 53.95 |
| 11:44 ET | 900 | 53.98 |
| 11:45 ET | 4900 | 54.06 |
| 11:47 ET | 4378 | 53.98 |
| 11:51 ET | 100 | 54.08 |
| 11:54 ET | 400 | 53.945 |
| 11:56 ET | 3477 | 53.75 |
| 11:58 ET | 800 | 53.8 |
| 12:00 ET | 1470 | 53.57 |
| 12:02 ET | 700 | 53.645 |
| 12:03 ET | 800 | 53.78 |
| 12:05 ET | 800 | 53.78 |
| 12:07 ET | 700 | 53.83 |
| 12:12 ET | 200 | 53.805 |
| 12:14 ET | 200 | 53.845 |
| 12:16 ET | 200 | 53.835 |
| 12:18 ET | 1200 | 53.75 |
| 12:20 ET | 300 | 53.72 |
| 12:21 ET | 100 | 53.805 |
| 12:23 ET | 800 | 53.765 |
| 12:25 ET | 710 | 53.85 |
| 12:27 ET | 600 | 53.88 |
| 12:30 ET | 1400 | 53.89 |
| 12:32 ET | 850 | 53.97 |
| 12:34 ET | 600 | 54.085 |
| 12:36 ET | 500 | 53.85 |
| 12:38 ET | 600 | 53.745 |
| 12:39 ET | 525 | 53.685 |
| 12:41 ET | 1287 | 53.82 |
| 12:43 ET | 202 | 53.81 |
| 12:45 ET | 200 | 53.82 |
| 12:50 ET | 400 | 53.81 |
| 12:52 ET | 200 | 53.87 |
| 12:54 ET | 400 | 53.815 |
| 12:56 ET | 800 | 53.68 |
| 12:57 ET | 100 | 53.76 |
| 12:59 ET | 240 | 53.81 |
| 01:01 ET | 100 | 53.83 |
| 01:03 ET | 500 | 53.81 |
| 01:06 ET | 200 | 53.86 |
| 01:08 ET | 705 | 53.785 |
| 01:10 ET | 2676 | 53.79 |
| 01:12 ET | 600 | 53.77 |
| 01:14 ET | 400 | 53.815 |
| 01:15 ET | 700 | 54 |
| 01:17 ET | 200 | 54.035 |
| 01:21 ET | 2300 | 53.865 |
| 01:24 ET | 200 | 53.825 |
| 01:26 ET | 600 | 53.785 |
| 01:28 ET | 500 | 53.75 |
| 01:30 ET | 600 | 53.755 |
| 01:32 ET | 341 | 53.8 |
| 01:33 ET | 100 | 53.81 |
| 01:37 ET | 200 | 53.8 |
| 01:42 ET | 300 | 53.815 |
| 01:44 ET | 200 | 53.815 |
| 01:46 ET | 400 | 53.81 |
| 01:48 ET | 400 | 53.795 |
| 01:50 ET | 100 | 53.82 |
| 01:51 ET | 1300 | 53.86 |
| 01:53 ET | 200 | 53.835 |
| 01:55 ET | 300 | 53.845 |
| 02:00 ET | 412 | 53.905 |
| 02:02 ET | 887 | 53.85 |
| 02:04 ET | 2242 | 53.88 |
| 02:06 ET | 1969 | 53.85 |
| 02:08 ET | 460 | 53.86 |
| 02:09 ET | 1200 | 53.85 |
| 02:13 ET | 200 | 53.8675 |
| 02:15 ET | 742 | 53.74 |
| 02:18 ET | 100 | 53.79 |
| 02:20 ET | 700 | 53.79 |
| 02:22 ET | 700 | 53.7 |
| 02:24 ET | 1000 | 53.82 |
| 02:26 ET | 2703 | 53.875 |
| 02:27 ET | 1200 | 53.97 |
| 02:29 ET | 300 | 54.07 |
| 02:36 ET | 400 | 54.06 |
| 02:38 ET | 100 | 54.03 |
| 02:40 ET | 300 | 54.05 |
| 02:42 ET | 100 | 53.99 |
| 02:44 ET | 1586 | 54.21 |
| 02:45 ET | 1360 | 53.84 |
| 02:47 ET | 400 | 53.835 |
| 02:49 ET | 300 | 53.895 |
| 02:54 ET | 400 | 53.89 |
| 02:56 ET | 300 | 53.98 |
| 03:00 ET | 200 | 53.91 |
| 03:02 ET | 700 | 53.98 |
| 03:03 ET | 900 | 53.97 |
| 03:05 ET | 700 | 53.91 |
| 03:07 ET | 1500 | 53.82 |
| 03:09 ET | 1451 | 53.7 |
| 03:12 ET | 800 | 53.805 |
| 03:14 ET | 200 | 53.835 |
| 03:16 ET | 800 | 53.79 |
| 03:18 ET | 800 | 53.91 |
| 03:20 ET | 2944 | 53.87 |
| 03:21 ET | 1600 | 53.89 |
| 03:23 ET | 1000 | 54.01 |
| 03:25 ET | 1900 | 54.06 |
| 03:27 ET | 500 | 54.02 |
| 03:30 ET | 1700 | 54.09 |
| 03:32 ET | 1400 | 54.03 |
| 03:34 ET | 300 | 54.08 |
| 03:36 ET | 3600 | 54.15 |
| 03:38 ET | 500 | 54.1 |
| 03:39 ET | 400 | 54.06 |
| 03:41 ET | 3953 | 53.97 |
| 03:43 ET | 4459 | 53.835 |
| 03:45 ET | 2304 | 53.985 |
| 03:48 ET | 39890 | 53.935 |
| 03:50 ET | 4279 | 53.915 |
| 03:52 ET | 11850 | 53.89 |
| 03:54 ET | 5828 | 53.955 |
| 03:56 ET | 20919 | 53.735 |
| 03:57 ET | 15233 | 53.665 |
| 03:59 ET | 109302 | 53.75 |
May 31, 2024
DJ Arcellx Initiated at Overweight by Piper Sandler, from 6:00AM ET on Friday May 31, 2024 by Dow Jones
6:00AM ET on Friday May 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Arcellx Inc | 2.9B | -51.7x | --- |
Rhythm Pharmaceuticals Inc | 2.6B | -8.9x | --- |
IDEAYA Biosciences Inc | 2.9B | -18.8x | --- |
SpringWorks Therapeutics Inc | 2.9B | -7.1x | --- |
Geron Corp | 2.9B | -13.5x | --- |
Biohaven Ltd | 3.0B | -4.8x | --- |
Company Information
Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).
Contact Information
- Headquarters
- 800 Bridge ParkwayREDWOOD CITY, CA, United States 94065
- Phone
- 240-327-0603
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Rami Elghandour
- Chief Financial Officer
- Michelle Gilson
- Chief Medical Officer
- Christopher Heery
- Independent Director
- Ali Behbahani
- Independent Director
- Jill Carroll
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $131.7M |
Shares Outstanding | 53.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.04 |
Book Value | $9.28 |
P/E Ratio | -51.7x |
Price/Sales (TTM) | 22.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
